Merck & Co., Inc.
MRK
Classificação em ações
#40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Preço da ação
$148.36
Valor de mercado
$366.02B
Variação (1 dia)
3.31%
Variação (1 ano)
71.87%
País
US
Negociar Merck & Co., Inc. (MRK)
Categoria
Healthcare
Lucros da Merck & Co., Inc. (MRK)
Lucros em Jun 2026 TTM: $5.95B
De acordo com os últimos relatórios financeiros da Merck & Co., Inc., os ganhos atuais da empresa são de $5.95B. Em 2024, a empresa teve ganhos de $19.94B, um aumento em relação a aos ganhos de 2023, que foram de $1.89B. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Merck & Co., Inc. de 2000 a 2026
Lucros no final de cada ano
| Ano | Lucros | Alterar |
|---|---|---|
| 2026 (TTM) | $5.95B | -71.77% |
| 2025 | $21.07B | 5.67% |
| 2024 | $19.94B | 955.37% |
| 2023 | $1.89B | -88.51% |
| 2022 | $16.44B | 18.48% |
| 2021 | $13.88B | 136.72% |
| 2020 | $5.86B | -18.24% |
| 2019 | $7.17B | -17.58% |
| 2018 | $8.70B | 33.43% |
| 2017 | $6.52B | 39.97% |
| 2016 | $4.66B | -13.74% |
| 2015 | $5.40B | -68.75% |
| 2014 | $17.28B | 211.69% |
| 2013 | $5.55B | -36.55% |
| 2012 | $8.74B | 19.16% |
| 2011 | $7.33B | 343.68% |
| 2010 | $1.65B | -89.19% |
| 2009 | $15.29B | 53.96% |
| 2008 | $9.93B | 194.63% |
| 2007 | $3.37B | -45.82% |
| 2006 | $6.22B | -15.51% |
| 2005 | $7.36B | -7.98% |
| 2004 | $8.00B | -11.59% |
| 2003 | $9.05B | -6.22% |
| 2002 | $9.65B | -2.98% |
| 2001 | $9.95B | 1.26% |
| 2000 | $9.82B | 0.00% |
Lucros de empresas semelhantes ou concorrentes
| Empresa | Lucros | Diferença de Lucros | País |
|---|---|---|---|
| $33.60B | 464.82% |
US
|
|
| $17.74B | 198.20% |
US
|
|
| $8.70B | 46.25% |
US
|
|
| $21.39B | 259.59% |
CH
|
|
| $16.38B | 175.36% |
CH
|
